Video

Common Presenting Factors for NSCLC

Common Presenting Factors for NSCLC

By Edward Garon, MD

Lung Cancer, Video

Dr. Edward Garon provides an overview of the most common presenting clinical features in adults with non-small cell lung cancer (NSCLC). Read More ›

Shifts in Lung Cancer Treatment

Shifts in Lung Cancer Treatment

By Edward Garon, MD

Lung Cancer, Video

Dr. Edward Garon reviews how certain drugs can change the landscape for treating patients with lung cancer. Read More ›

A Look at PD-1 and PD-L1 Inhibitors

A Look at PD-1 and PD-L1 Inhibitors

By Edward Garon, MD

Lung Cancer, Video

Dr. Edward Garon discusses the use of PD-1 and PD-L1 inhibitors in patients with lung cancer. Read More ›

ALK Gene Rearrangement and PD-L1 Expression

ALK Gene Rearrangement and PD-L1 Expression

By Edward Garon, MD

Lung Cancer, Video

Dr. Edward Garon does not believe there is much value in utilizing PD-L1 inhibitors for pateints with ALK gene rearrangement. Read More ›

Differences in NSCLC Patient Populations

Differences in NSCLC Patient Populations

By Edward Garon, MD

Lung Cancer, Video

Dr. Edward Garon speaks about how differences in patient populations with lung cancer can make it difficult to interpret and act on data. Read More ›

Choosing the Right Therapy for Patients with NSCLC

Choosing the Right Therapy for Patients with NSCLC

By Edward Garon, MD

Lung Cancer, Video

Dr. Edward Garon shares an anecdote about an interesting NSCLC case from his practice. Read More ›

Immunotherapies and Lung Cancer

Immunotherapies and Lung Cancer

By Edward Garon, MD

Lung Cancer, Video

Dr. Edward Garon explains how he discusses immunotherapies with patients. Read More ›

My Practice: Roles and Responsibilities

My Practice: Roles and Responsibilities

By Edward Garon, MD

Lung Cancer, Video

Dr. Edward Garon describes how staff at his practice interacts with patients. Read More ›

Challenges in Managing Toxicities

Challenges in Managing Toxicities

By Edward Garon, MD

Lung Cancer, Video

Dr. Edward Garon believes it's important to recognize that agents without efficacy are not beneficial to the patient despite low toxicity. Read More ›

Monitoring for Bone Health

Monitoring for Bone Health

By Angela Hunter, BSN; Pam Skurkay, RN, BSN, CPAN, CURN; Dianna Shafer, BSN, CURN, CPN, CPC-I

Genitourinary Cancers, Video

TON Interview with the Innovators: Volume 1

Dianna Shafer talks about the testing protocol when examining patients’ bones and what they prescribe to ensure their patients’ bone health is being addressed. Read More ›

Page 7 of 10

1
2
3
4
5
6
7
8
9
10

Subscribe Today!

To sign up for our newsletter or print publications, please enter your contact information below.

I'd like to receive:

TON Print Edition

TON Weekly e‑Newsletter

I have reviewed and consent to the terms of TON's Privacy Policy, and TON has my permission to retain my information in its database, and to forward pertinent communications to me.